<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Maerz MD</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>National Institutes of Health</funding><pubmed_abstract>γδ T cells expressing a Vδ1/3+ T cell receptor are enriched at mucosal surfaces, but their role in protection against Mycobacterium tuberculosis (Mtb) is largely unknown. We used multimodal single-cell RNA sequencing, mass cytometry, and flow cytometry to profile γδ T cells from human infants and macaques after protective vaccination with Mycobacterium bovis bacillus Calmette Guerin (BCG). A subset of Vδ1/3 T cells in BCG-vaccinated human infants shows evidence of clonal expansion and differentiation into Mtb-reactive cytotoxic effector cells. In macaques, intravenous BCG induces pro-inflammatory and cytotoxic responses to Mtb among Vδ1/3 T cells that are enriched in the airway compared to the blood. Finally, the frequency of cytokine-expressing Vδ1/3 T cells in the airway is associated with protection against Mtb challenge. Thus, Vδ1/3 T cells are activated by BCG and accumulate in the lung, where they upregulate cytotoxic and pro-inflammatory functions that may contribute to protective immunity against Mtb.</pubmed_abstract><journal>Cell reports. Medicine</journal><pagination>102536</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12866138</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>BCG vaccination induces antibacterial effector functions among Vδ1/3 T cells that are associated with protection against tuberculosis.</pubmed_title><pmcid>PMC12866138</pmcid><pubmed_authors>Bucsan AN</pubmed_authors><pubmed_authors>Bishop E</pubmed_authors><pubmed_authors>Roederer M</pubmed_authors><pubmed_authors>Layton ED</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Sutton MS</pubmed_authors><pubmed_authors>Seder RA</pubmed_authors><pubmed_authors>Maerz MD</pubmed_authors><pubmed_authors>Tian Z</pubmed_authors><pubmed_authors>Shalek AK</pubmed_authors><pubmed_authors>Darrah PA</pubmed_authors><pubmed_authors>Scriba TJ</pubmed_authors><pubmed_authors>Makatsa MS</pubmed_authors><pubmed_authors>Seshadri C</pubmed_authors></additional><is_claimable>false</is_claimable><name>BCG vaccination induces antibacterial effector functions among Vδ1/3 T cells that are associated with protection against tuberculosis.</name><description>γδ T cells expressing a Vδ1/3+ T cell receptor are enriched at mucosal surfaces, but their role in protection against Mycobacterium tuberculosis (Mtb) is largely unknown. We used multimodal single-cell RNA sequencing, mass cytometry, and flow cytometry to profile γδ T cells from human infants and macaques after protective vaccination with Mycobacterium bovis bacillus Calmette Guerin (BCG). A subset of Vδ1/3 T cells in BCG-vaccinated human infants shows evidence of clonal expansion and differentiation into Mtb-reactive cytotoxic effector cells. In macaques, intravenous BCG induces pro-inflammatory and cytotoxic responses to Mtb among Vδ1/3 T cells that are enriched in the airway compared to the blood. Finally, the frequency of cytokine-expressing Vδ1/3 T cells in the airway is associated with protection against Mtb challenge. Thus, Vδ1/3 T cells are activated by BCG and accumulate in the lung, where they upregulate cytotoxic and pro-inflammatory functions that may contribute to protective immunity against Mtb.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-02T03:15:06.076Z</modification><creation>2026-07-02T03:08:27.859Z</creation></dates><accession>S-EPMC12866138</accession><cross_references><pubmed>41529694</pubmed><doi>10.1016/j.xcrm.2025.102536</doi></cross_references></HashMap>